Testing Hypotheses of Covariate-Adaptive Randomized Clinical Trials
暂无分享,去创建一个
Feifang Hu | Wei Ma | Li-Xin Zhang | F. Hu | Li-Xin Zhang | Wei Ma
[1] A. Forsythe,et al. Validity and power of tests when groups have been balanced for prognostic factors , 1987 .
[2] Li-Xin Zhang,et al. Asymptotic properties of covariate-adjusted response-adaptive designs , 2006 .
[3] Jun Shao,et al. A theory for testing hypotheses under covariate-adaptive randomization , 2010 .
[4] L. H. Snyder,et al. Tests of Simple Mendelian Inheritance in Randomly Collected Data of One and Two Generations , 1939 .
[5] F. Hu,et al. Asymptotic properties of covariate-adaptive randomization , 2012, 1210.4666.
[6] B. Efron. Forcing a sequential experiment to be balanced , 1971 .
[7] B. Griffith,et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. , 2006, The New England journal of medicine.
[8] C. Gridelli,et al. Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] William F. Rosenberger,et al. Handling Covariates in the Design of Clinical Trials. , 2008, 1102.3773.
[10] D R Taves,et al. Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.
[11] F. Hu,et al. Covariate-adjusted response-adaptive designs for generalized linear models , 2014 .
[12] R. Simon,et al. Restricted randomization designs in clinical trials. , 1979, Biometrics.
[13] S. Pocock,et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. , 2012, JAMA.
[14] Feifang Hu,et al. ST ] 1 7 O ct 2 00 6 ASYMPTOTIC PROPERTIES OF COVARIATE-ADJUSTED ADAPTIVE DESIGNS , 2006 .
[15] Feifang Hu,et al. Balancing continuous covariates based on Kernel densities. , 2013, Contemporary clinical trials.
[16] Dongsheng Tu,et al. Adjustment of Treatment Effect for Covariates in Clinical Trials: Statistical and Regulatory Issues , 2000 .
[17] D. Taves,et al. The use of minimization in clinical trials. , 2010, Contemporary clinical trials.
[18] Alexander A. Morgan,et al. Clinical assessment incorporating a personal genome , 2010, The Lancet.
[19] Russ B. Altman,et al. Clinical evaluation incorporating a personal genome , 2010 .
[20] Hongyu Zhao,et al. Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker , 2013 .
[21] L. J. Wei,et al. An Application of an Urn Model to the Design of Sequential Controlled Clinical Trials , 1978 .
[22] C B Begg,et al. A treatment allocation procedure for sequential clinical trials. , 1980, Biometrics.
[23] Mikel Aickin,et al. A Simulation Study of the Validity and Efficiency of Design-Adaptive Allocation to Two Groups in the Regression Situation , 2009, The international journal of biostatistics.
[24] Zhifu Sun,et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. , 2010, The Lancet. Oncology.
[25] M Zelen,et al. The randomization and stratification of patients to clinical trials. , 1974, Journal of chronic diseases.
[26] A. Atkinson. Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .
[27] M. Lebwohl,et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. , 2007, The New England journal of medicine.
[28] N. Birkett,et al. Adaptive allocation in randomized controlled trials. , 1985, Controlled clinical trials.
[29] Stephen B Gruber,et al. Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer , 2010, Cancer Prevention Research.
[30] T. Watts,et al. Clinical and radiographic evaluation of one-and two-visit endodontic treatment of asymptomatic necrotic teeth with apical periodontitis: a randomized clinical trial , 2008, BDJ.
[31] S. Kishida,et al. Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica , 2012, European Spine Journal.
[32] D P Byar,et al. The effect of stratified randomization on size and power of statistical tests in clinical trials. , 1978, Journal of chronic diseases.
[33] J. R. Landis,et al. The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. , 1976, Journal of chronic diseases.
[34] William F. Rosenberger,et al. Implementing Optimal Allocation in Sequential Binary Response Experiments , 2007 .
[35] Damian McEntegart,et al. The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview , 2003 .
[36] Richard L. Tweedie,et al. Markov Chains and Stochastic Stability , 1993, Communications and Control Engineering Series.
[37] S. Pocock,et al. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.
[38] Yunzhi Lin,et al. Balancing continuous and categorical baseline covariates in sequential clinical trials using the area between empirical cumulative distribution functions , 2012, Statistics in medicine.
[39] R. Stephens,et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome , 2000, British Journal of Cancer.
[40] Feifang Hu. Statistical issues in trial design and personalized medicine , 2012 .
[41] Jianhua Hu,et al. A Unified Family of Covariate-Adjusted Response-Adaptive Designs Based on Efficiency and Ethics , 2015, Journal of the American Statistical Association.